October 8, 2013 — Terumo Interventional Systems, a division of Terumo Medical Corp., announced the nationwide availability of the Azur CX Peripheral Coil System (Azur CX), the first and only peripheral embolization coil designed to provide cross-sectional coverage incorporating the benefits of Terumo's hydrogel technology.
The Azur CX is an expansion of Terumo's Azur family of embolization coils for endovascular occlusion of peripheral vessels. Its coil contains hydrogel on the inside for a soft, flexible design. The hydrogel technology creates a scaffold for neointimal growth formation and allows mechanical occlusion of the vessel with less reliance on thrombus for embolization. The Azur CX creates a shape that enhances cross-sectional coverage by filling the vessel and leaving no gap in the center. It can be deployed with minimal catheter manipulation.
"Placing embolic coils in high-flow vessels is always a challenge because of the possibility the coil will move after placement. Maintaining control is critical," said Frank Arko III, M.D., Sanger Heart and Vascular Institute, Carolinas Medical Center. "The coil has minimal preparation time and with the Azur Detachment Controller I can achieve precise placement."
Compared to traditional embolic coils, detachable coils offer more precise positioning, allowing physicians to extend further into more tortuous anatomy, where distal embolization is a concern.
For more information: www.terumois.com